Literature DB >> 812890

The relation of anticonvulsant drug levels to complete seizure control.

R G Feldman, C E Pippenger.   

Abstract

This study was undertaken to determine the relationship of serum ACD levels to dosage in a group of patients who had been seizure free for at least two years. It demonstrated that some patients remain completely seizure free with DPH and/or phenobarbital serum concentrations which are well below the reported "optimal" therapeutic ranges. In addition, medicating patients with anti-convulsant drugs solely on the basis of mg/kg of body weight does not assure optimal ACD levels in any given patient. Certain patients can be maintained completely seizure free controlled with DPH and/or Pb levels of less than 10 micrograms/ml. There are several explanations for the medication concentrations observed in these patients: (1) patient noncompliance in ingestion of prescribed medication; (2) altered drug utilization; (3) a mild focus which is maintained under control with lower DPH levels than those necessary to control a more active focus; or (4) epilepsy in remission. Our observations emphasize the importance of individual regulation of medications for seizure control.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 812890     DOI: 10.1002/j.1552-4604.1976.tb01491.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Therapeutic drug monitoring--antiepileptic drugs.

Authors:  M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

3.  Overuse of monitoring of blood concentrations of antiepileptic drugs.

Authors:  M J Brodie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

Review 4.  Is there a role for therapeutic drug monitoring of new anticonvulsants?

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

5.  The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.

Authors:  G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 6.  Rational usage of therapeutic drug monitoring in antiepileptic treatment.

Authors:  H Bartels
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

7.  [Selected clinical aspects of routine monitoring of anticonvulsant concentrations in serum (author's transl)].

Authors:  R Heipertz; H Pilz; K Eickhoff; D Seidel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

Review 8.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 9.  Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach.

Authors:  Rachel G Greenberg; Chiara Melloni; Huali Wu; Daniel Gonzalez; Lawrence Ku; Kevin D Hill; Christoph P Hornik; Michael Cohen-Wolkowiez; Jeffrey T Guptill
Journal:  Clin Neuropharmacol       Date:  2016 Sep-Oct       Impact factor: 1.379

10.  Identification and prevention of antiepileptic drug noncompliance: the collaborative use of state-supplied pharmaceutical data.

Authors:  Joseph C Hodges; Janet Treadwell; Amy D Malphrus; Xuan G Tran; Angelo P Giardino
Journal:  ISRN Pediatr       Date:  2014-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.